|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
He YT, Li DJ, Liang D, Zheng RS, Zhang SW,
Zeng HM, Chen WQ and He J: Incidence and mortality of bladder
cancer in China, 2014. Zhonghua Zhong Liu Za Zhi. 40:647–652.
2018.(In Chinese). PubMed/NCBI
|
|
3
|
Kaufman DS, Shipley WU and Feldman AS:
Bladder cancer. Lancet. 374:239–249. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen M, Zhuang C, Liu Y, Li J, Dai F, Xia
M, Zhan Y, Lin J, Chen Z, He A, et al: Tetracycline-inducible shRNA
targeting antisense long non-coding RNA HIF1A-AS2 represses the
malignant phenotypes of bladder cancer. Cancer Lett. 376:155–164.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen M, Li J, Zhuang C and Cai Z:
Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of
bladder cancer. Oncotarget. 8:28176–28186. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tran MN, Goodwin JG, Mcconkey DJ and Kamat
AM: Bladder cancer stem cells. Curr Stem Cell Res Ther. 5:387–395.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Padhye SS, Guin S, Yao HP, Zhou YQ, Zhang
R and Wang MH: Sustained expression of the RON receptor tyrosine
kinase by pancreatic cancer stem cells as a potential targeting
moiety for antibody-directed chemotherapeutics. Mol Pharm.
8:2310–2329. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sukowati CH, Rosso N, Crocè LS and
Tiribelli C: Hepatic cancer stem cells and drug resistance:
Relevance in targeted therapies for hepatocellular carcinoma. World
J Hepatol. 2:114–126. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ploeg M, Aben KKH and Kiemeney LA: The
present and future burden of urinary bladder cancer in the world.
World J Urol. 27:289–293. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bi W, Hayes RB, Feng P, Qi Y, You X, Zhen
J, Zhang M, Qu B, Fu Z, Chen M, et al: Mortality and incidence of
bladder cancer in benzidine-exposed workers in China. Am J Ind Med.
21:481–489. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Talaska G: Aromatic amines and human
urinary bladder cancer: Exposure sources and epidemiology. J
Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 21:29–43.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Letašiová S, Medve'ová A, Šovčíková A,
Dušinská M, Volkovová K, Mosoiu C and Bartonová A: Bladder cancer,
a review of the environmental risk factors. Environ Health. 11
(Suppl 1):S112012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Brown SC, Alberts R and Schoenberg M:
Cancer incidence and mortality among workers exposed to benzidine.
Am J Ind Med. 54:300–306. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Park J, Shin KS and Kim Y: Occupational
reproductive function abnormalities and bladder cancer in Korea. J
Korean Med Sci. 25 (Suppl 1):S41–S45. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhu GD, Zhau HY, Wu DP, Song WB, He DL and
Chung L: Sonic hedgehog signaling in normal human bladder
development. J Urol. 195:E4122016. View Article : Google Scholar
|
|
16
|
Walter K, Omura N, Hong SM, Griffith M,
Vincent A, Borges M and Goggins M: Overexpression of smoothened
activates the sonic hedgehog signaling pathway in pancreatic
cancer-associated fibroblasts. Clin Cancer Res. 16:1781–1789. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Song Z, Du Y and Tao Y: Blockade of sonic
hedgehog signaling decreases viability and induces apoptosis in
retinoblastoma cells: The key role of the PI3K/Akt pathway. Oncol
Lett. 14:4099–4105. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Varjosalo M and Taipale J: Hedgehog:
Functions and mechanisms. Genes Dev. 22:2454–2472. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Syed IS, Pedram A and Farhat WA: Role of
sonic hedgehog (Shh) signaling in bladder cancer stemness and
tumorigenesis. Curr Urol Rep. 17:112016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gedye C and Ailles L: Isolation and
characterization of cancer stem cells in vitro. Methods Mol Biol.
946:181–204. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chan KS, Espinosa I, Chao M, Wong D,
Ailles L, Diehn M, Gill H, Presti J Jr, Chang HY, van de Rijn M, et
al: Identification, molecular characterization, clinical prognosis,
and therapeutic targeting of human bladder tumor-initiating cells.
Proc Natl Acad Sci USA. 106:14016–14021. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ning ZF, Huang YJ, Lin TX, Zhou YX, Jiang
C, Xu KW, Huang H, Yin XB and Huang J: Subpopulations of stem-like
cells in side population cells from the human bladder transitional
cell cancer cell line T24. J Int Med Res. 37:621–630. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
She JJ, Zhang PG, Wang ZM, Gan WM and Che
XM: Identification of side population cells from bladder cancer
cells by DyeCycle Violet staining. Cancer Biol Ther. 7:1663–1668.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Williams A, Datar R and Cote R:
Technologies and methods used for the detection, enrichment and
characterization of cancer stem cells. Natl Med J India.
23:346–350. 2010.PubMed/NCBI
|
|
25
|
Wang D, Kong X, Li Y, Qian W, Ma J, Wang
D, Yu D and Zhong C: Curcumin inhibits bladder cancer stem cells by
suppressing sonic hedgehog pathway. Biochem Biophys Res Commun.
493:521–527. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yi SY, Hao YB, Nan KJ and Fan TL: Cancer
stem cells niche: A target for novel cancer therapeutics. Cancer
Treat Rev. 39:290–296. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vineis P and Pirastu R: Aromatic amines
and cancer. Cancer Causes Control. 8:346–355. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rosenman KD and Reilly MJ: Cancer
mortality and incidence among a cohort of benzidine and
dichlorobenzidine dye manufacturing workers. Am J Ind Med.
46:505–512. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sun X, Zhang T, Deng Q, Zhou Q, Sun X, Li
E, Yu D and Zhong C: Benzidine induces epithelial-mesenchymal
transition of human bladder cancer cells through activation of ERK5
pathway. Mol Cells. 41:188–197. 2018.PubMed/NCBI
|
|
30
|
Islam SS, Mokhtari RB, Noman AS, Uddin M,
Rahman MZ, Azadi MA, Zlotta A, van der Kwast T, Yeger H and Farhat
WA: Sonic hedgehog (Shh) signaling promotes tumorigenicity and
stemness via activation of epithelial-to-mesenchymal transition
(EMT) in bladder cancer. Mol Carcinog. 55:537–551. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
DeSouza KR, Saha M, Carpenter AR, Scott M
and McHugh KM: Analysis of the sonic hedgehog signaling pathway in
normal and abnormal bladder development. PLoS One. 8:e536752013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nedjadi T, Salem N, Khayyat D, Al-Sayyad
A, Al-Ammari A and Al-Maghrabi J: Sonic hedgehog expression is
associated with lymph node invasion in urothelial bladder cancer.
Pathol Oncol Res. 25:1067–1073. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shin K, Lee J, Guo N, Kim J, Lim A, Qu L,
Mysorekar IU and Beachy PA: Hedgehog/Wnt feedback supports
regenerative proliferation of epithelial stem cells in bladder.
Nature. 472:110–114. 2011. View Article : Google Scholar : PubMed/NCBI
|
